2013
20 Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Research, 2013; 41(Database issue):D793-800.
2012
19 Dreher F, Kreitler T, Hardt C, Kamburov A, Yildirimman R, Schellander K, Lehrach H, Lange BMH, Herwig R. DIPSBC - Data Integration Platform for Systems Biology Collaborations. BMC Bioinformatics. 2012 May 8;13:85. doi: 10.1186/1471-2105-13-85.
18 Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35(1):31-9. Epub 2011 Dec 15.
17 Schuchardt M, Tölle M, Prüfer J, Prüfer N, Huang T, Jankowski V, Jankowski J, Zidek W, van der Giet M. Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int. 2012 Feb;81(3):256-65
2011
16 Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010 Nov;9(11)
15 Jankowski V, Tölle M, Santos RA, Günthner T, Krause E, Beyermann M, Welker P, Bader M, Pinheiro SV, Sampaio WO, Lautner R, Kretschmer A, van der Giet M, Zidek W, Jankowski J. Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J. 2011 Sep;25(9):2987-95. Epub 2011 May 31.
14 Kamburov A, Cavill R, Ebbels TMD, Herwig R, Keun HC. Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics, 2011 Oct; 27(20):2917-2918. doi: 10.1093/bioinformatics/btr499
13 Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35(1):31-9. Epub 2011 Dec 15.
12 Schuchardt M, Prüfer J, Prüfer N, Wiedon A, Huang T, Chebli M, Jankowski V, Jankowski J, Schäfer-Korting M, Zidek W, van der Giet M, Tölle M. The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl). 2011
11 Wiedon A, Tölle M, Bastine J, Schuchardt M, Huang T, Jankowski V, Jankowski J, Zidek W, van der Giet M. Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun. 2012 Jan 20;417(3):1035-40. Epub 2011 Dec 26.
2010
10 Brettschneider F, Jankowski V, Günthner T, Salem S, Nierhaus M, Schulz A, Zidek W, Jankowski J. Replacement of acetonitrile by ethanol as solvent in reversed phase chromatography of biomolecules. J Chromatogr B Analyt Technol Biomed Life Sci. 2010
9 Liu Y, Thilo F, Kreutz R, Schulz A, Wendt N, Loddenkemper C, Jankowski V, Tepel M. Tissue expression of TRPC3 and TRPC6 in hypertensive Munich Wistar Frömter rats showing proteinuria.. Am J Nephrol. 2010;31(1):36-44. Epub 2009 Oct 30
8 Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Cohen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation.; Blood Purif. 2010;30(4):277-87.
7 Schepers E, Glorieux G, Jankowski V, Dhondt A, Jankowski J, Vanholder R. Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst. Nephrol Dial Transplant. 2010 Aug;25(8):2636-44. Epub 2010 Feb 26.
6 Scholze A, Katharina Krueger, Madeleine Diedrich, Christine Rath, Anja Torges, Vera Jankowski, Alexandra Maier, Florian Thilo, Walter Zidek, Martin Tepel: Superoxide dismutase type 1 in monocytes of chronic kidney disease patients. Amino Acids. 2010 Oct 8. [Epub ahead of print]
5 Tölle M, Schuchardt M, Wiedon A, Huang T, Klöckel L, Jankowski J, Jankowski V, Zidek W, van der Giet M. Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney.Br J Pharmacol. 2010 Oct;161(3):530-40
2009
4 Guenthner T, Jankowski V, Kretschmer A, Nierhaus M, van der Giet M, Zidek W, Jankowski J. Endothelium and vascular smooth muscle cells in the context of uremia. Semin Dial. 2009;22(4):428-432.
3 Herget-Rosenthal S, Glorieux G, Jankowski J, Jankowski V. Uremic toxins in acute kidney injury. Semin Dial. 2009;22(4):445-448.
2 Jankowski V, Gunthner T, Herget-Rosenthal S, Zidek W, Jankowski J. Dinucleoside polyphosphates and uremia. Semin Dial. 2009;22(4):396-399.
1 Jankowski V, van der Giet M, Mischak H, Morgan M, Zidek W, Jankowski J. Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system. Br J Pharmacol. 2009;157(7):1142-1153.
